ArticleBMC cancer2025

METTL16-dependent miR-146b-5p m6A modification remodeling sensitize NSCLC to osimertinib via activating PI3K/AKT signaling.

Hongyang Sang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.